Southwest Research Institute broke ground today on a new 21,000-square-foot Clinical Supply Facility to support government and industry clients with integrated pharmaceutical and bioengineering research and development. The new facility expands our bioengineering laboratory footprint and adds dedicated bioengineering production suites with filtered air and low airborne particulate counts. The Clinical Supply Facility will allow us to produce in vitro stem cells, certain types of vaccines and small molecule therapeutics in a clean environment at scales able to facilitate clinical trials for our clients.
" Darrel Johnston, Director of SwRI's Pharmaceutical and Bioengineering Department SwRI plays an important role in San Antonio's highly collaborative biomedical ecosystem. As a pioneer in microencapsulation, bioengineering and pharmaceutical development, the Institute can assist clients with important research and development projects of all sizes, including small batches of therapeutics for rare diseases involving fewer than 200 units. "We help develop clinical supplies both for active pharmaceutical ingredients as well as the formulated products needed for clinical studies," said Dr.
Joe McDonough, vice president of SwRI's Chemistry and Chemical Engineering Division. "SwRI can guide clients step-by-step from the initial concept phase through drug discovery and the FDA approvals process. Using our expansive facilities, we support our clients with the development of their clinic.
